연구
연구업적
최근 5년 연구업적 현황
| 연도 | 2025년 | 2024년 | 2023년 | 2022년 | 2021년 | |
|---|---|---|---|---|---|---|
| SCI 논문 발표편수 |
책임 | 196편 | 179편 | 173편 | 163편 | 184편 |
| 공동 | 132편 | 147편 | 120편 | 115편 | 136편 | |
| 합계 | 328편 | 326편 | 293편 | 278편 | 320편 | |
735. Development of acetylated HDD kit for preparation of 188Re-HDD/lipiodol.
Lee YS, Jeong JM, Kim YJ, Chang YS, Lee HJ, Son M, Lee JW, Yoon HS, Kang WJ, Lee DS, Chung JK, Lee MC, Suh YG.
Appl Radiat Isot. 2007 Jan;65(1):64-9. Epub 2006 Sep 28.
Link
734. Dibutyryl cAMP stimulates the proliferation of SH-SY5Y human neuroblastoma cells by up-regulating Skp2 protein.
Cho CH, Seo M, Lee YI, Kim SY, Youn HD, Juhnn YS.
J Cancer Res Clin Oncol. 2007 Feb;133(2):135-44. Epub 2006 Sep 27
Link
733. Inhibition of gamma ray-induced apoptosis by stimulatory heterotrimeric GTP binding protein involves Bcl-xL down-regulation in SH-SY5Y human neuroblastoma cells.
Kim SY, Seo M, Oh JM, Cho EA, Juhnn YS.
Exp Mol Med. 2007 Oct 31;39(5):583-93
Link
732. G Protein betagamma subunits augment UVB-induced apoptosis by stimulating the release of soluble heparin-binding epidermal growth factor from human keratinocytes.
Seo M, Lee MJ, Heo JH, Lee YI, Kim Y, Kim SY, Lee ES, Juhnn YS.
J Biol Chem. 2007 Aug 24;282(34):24720-30. Epub 2007 Jun 4
Link
731. Preclinical evaluation of YC-1, a HIF inhibitor, for the prevention of tumor spreading.
Shin DH, Kim JH, Jung YJ, Kim KE, Jeong JM, Chun YS, Park JW.
Cancer Lett. 2007 Sep 18;255(1):107-16. Epub 2007 May 14
Link
730. CITED2 mediates the paradoxical responses of HIF-1alpha to proteasome inhibition.
Shin DH, Li SH, Chun YS, Huang LE, Kim MS, Park JW.
Oncogene. 2007 Oct 1
Link
729. ATP6V0C competes with von Hippel-Lindau protein in hypoxia-inducible factor 1alpha (HIF-1alpha) binding and mediates HIF-1alpha expression by bafilomycin A1.
Lim JH, Park JW, Kim SJ, Kim MS, Park SK, Johnson RS, Chun YS.
Mol Pharmacol. 2007 Mar;71(3):942-8. Epub 2006 Dec 18
Link
728. HIF-1alpha promotes survival of prostate cells at a high zinc environment.
Park SE, ParK JW, Cho YS, Ryu JH, Paick JS, Chun YS,
Prostate.2007Oct 1;67(14):1514-23
Link
727. Phase II study of low-dose paclitaxel and cisplatin as a second-line therapy after 5-fluorouracil/platinum chemotherapy in gastric cancer.
Lee KW, Kim JH, Yun T, Song EK, Na II, Shin H, Oh SY, Choi IS, Oh do Y, Kim DW, Im SA, Kim TY, Lee JS, Heo DS, Bang YJ, Kim NK.
J Korean Med Sci. 2007 Sep;22 Suppl:S115-21
Link
726. Intron 1 CA dinucleotide repeat polymorphism and mutations of epidermal growth factor receptor and gefitinib responsiveness in non-small-cell lung cancer.
Han SW, Jeon YK, Lee KH, Keam B, Hwang PG, Oh DY, Lee SH, Kim DW, Im SA, Chung DH, Heo DS, Bang YJ, Kim TY.
Pharmacogenet Genomics. 2007 May;17(5):313-9
Link